No evidence for fibroblast growth factor receptor 3 (FGFR-3) R248C/S249C mutations in human prostate cancer

被引：0
|
作者：
Naimi, B
Latil, A
Berthon, P
Cussenot, O
机构：
[1] Univ Paris 07, CeRePP, EA 3104, F-91000 Evry, France
[2] Genopole, UroGene, F-91000 Evry, France
[3] Inst Anat St Peres, Paris, France
[4] Inst Univ France, Paris, France
来源：
INTERNATIONAL JOURNAL OF CANCER | 2000年 / 87卷 / 03期
关键词：
D O I：
10.1002/1097-0215(20000801)87:3<455::AID-IJC23>3.3.CO;2-H
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：455 / 456
页数：2
相关论文
共 50 条
  • [31] Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers
    Jang, JH
    Shin, KH
    Park, JG
    CANCER RESEARCH, 2001, 61 (09) : 3541 - 3543
  • [32] Human epidermal growth factor receptor 2 (HER2) and fibroblast growth factor receptor 3 (FGFR3) mutations to reveal biological pathways in urothelial carcinoma.
    Chu, Carissa Ellen
    Escano, Manuel De Jesus
    Yip, Wesley
    Jiang, Song
    Iyer, Gopa
    Al-Ahmadie, Hikmat A.
    Goh, Alvin C.
    Dalbagni, Guido
    Bochner, Bernard H.
    Solit, David B.
    Pietzak, Eugene J.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [33] Mutations in the fibroblast growth factor receptor 3 (FGFR3) cause achondroplasia, hypochondroplasia, and thanatophoric dysplasia: Taiwanese data
    Tsai, FJ
    Tsai, CH
    Chang, JG
    Wu, JY
    AMERICAN JOURNAL OF MEDICAL GENETICS, 1999, 86 (03): : 300 - 301
  • [34] Hypochondroplasia, achondroplasia, and thanatophoric dysplasia caused by mutations of the fibroblast-growth-factor-receptor-3-gene (FGFR3)
    Hilbert, M
    Hilbert, K
    Spranger, J
    Wildhardt, G
    Winterpacht, A
    Wuchner, C
    Zabel, B
    MONATSSCHRIFT KINDERHEILKUNDE, 1998, 146 (07) : 687 - 691
  • [35] Non-invasive detection of bladder cancer by digital PCR analysis of urine samples for the presence of the most common mutations: pilot study for the detection of S249C FGFR3 mutation
    Kiprijanovska, Sanja
    Dichevska, Hristina
    Trifunovski, Aleksandar
    Ivanovski, Ognen
    Saidi, Skender
    Popov, Zivko
    Dimovski, Aleksandar
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 923 - 923
  • [36] Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders
    Bas W G van Rhijn
    Angela A G van Tilborg
    Irene Lurkin
    Jacky Bonaventure
    Annie de Vries
    Jean-Paul Thiery
    Theodorus H van der Kwast
    Ellen C Zwarthoff
    Francois Radvanyi
    European Journal of Human Genetics, 2002, 10 : 819 - 824
  • [37] Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders
    van Rhijn, BWG
    van Tilborg, AAG
    Lurkin, I
    Bonaventure, J
    de Vries, A
    Thiery, JP
    van der Kwast, TH
    Zwarthoff, EC
    Radvanyi, F
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 (12) : 819 - 824
  • [38] Tinengotinib, a novel fibroblast growth factor receptor (FGFR) inhibitor, is potent against resistance mutations in FGFR1/2/3
    Qiang, Xiaoyan
    Yu, Qi
    Fan, Jean
    Wu, Frank
    Sun, Caixia
    Peng, Peng
    CANCER RESEARCH, 2023, 83 (08)
  • [39] The role of mutations and overexpression of the fibroblast growth factor receptor-3 in bladder cancer
    Wang, Q. Y.
    Zhao, Y.
    Zhang, R.
    MINERVA MEDICA, 2015, 106 (06) : 333 - 337
  • [40] Fibroblast Growth Factor Receptor (FGFR)3 sustains acquired resistance to trastuzumab in gastric cancer patients
    Piro, G.
    Carbone, C.
    Cataldo, I.
    Di Nicolantonio, F.
    Giacopuzzi, S.
    Boschi, F.
    Zanotto, M.
    Merz, V.
    Mina, M. M.
    Sbarbati, A.
    De Manzoni, G.
    Scarpa, A.
    Tortora, G.
    Melisi, D.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S42 - S43
12345